Faculty Bibliography

Background -Ambulatory blood pressure (BP) monitoring (ABPM) is the reference standard for out-of-clinic BP measurement. Thresholds for identifying ambulatory hypertension (daytime systolic BP [SBP]/diastolic BP [DBP] >/= 135/85 mmHg, 24-hour SBP/DBP >/= 130/80 mmHg, and nighttime SBP/DBP >/= 120/70 mmHg) have been derived from European, Asian and South American populations. We determined BP thresholds for ambulatory hypertension in a US population-based sample of African Americans. Methods -We analyzed data from the Jackson Heart Study (JHS), a population-based cohort study comprised exclusively of African-American adults (n=5,306). Analyses were restricted to 1,016 participants who completed ABPM at baseline in 2000-2004. Mean systolic BP (SBP) and diastolic BP (DBP) levels were calculated for daytime (10:00am-8:00pm), 24-hour (all available readings) and nighttime (midnight-6:00am) periods, separately. Daytime, 24-hour, and nighttime BP thresholds for ambulatory hypertension were identified using regression- and outcome-derived approaches. The composite of a cardiovascular disease (CVD) or all-cause mortality event was used in the outcome-derived approach. For this latter approach, BP thresholds were identified only for SBP as clinic DBP was not associated with the outcome. Analyses were stratified by antihypertensive medication use. Results -Among participants not taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mmHg were 134/85 mmHg, 130/81 mmHg, and 123/73 mmHg, respectively. The outcome-derived thresholds for daytime, 24-hour, and nighttime SBP corresponding to a clinic SBP >/= 140 mmHg were 138 mmHg, 134 mmHg, and 129 mmHg, respectively. Among participants taking antihypertensive medication, the regression-derived thresholds for daytime, 24-hour, and nighttime SBP/DBP corresponding to clinic SBP/DBP of 140/90 mmHg were 135/85 mmHg, 133/82 mmHg, and 128/76 mmHg, respectively. The corresponding outcome-derived thresholds for daytime, 24-hour, and nighttime SBP were 140 mmHg, 137 mmHg, and 133 mmHg, respectively, among those taking antihypertensive medication. Conclusions -Based on the outcome-derived approach for SBP and regression-derived approach for DBP, the following definitions for daytime hypertension, 24-hour hypertension, and nighttime hypertension corresponding to clinic SBP/DBP >/= 140/90 mmHg are proposed for African Americans: daytime SBP/DBP >/= 140/85 mmHg, 24-hour SBP/DBP >/= 135/80 mmHg, and nighttime SBP/DBP >/= 130/75 mmHg, respectively.

OBJECTIVES: This was a two-part descriptive study designed to (1) assess the marketing themes and sugar content of beverages promoted in outdoor advertisements (ads) within a portion of Accra, Ghana and (2) quantify the types of ads that appeared along the Accra-Cape Coast Highway. SETTING: A 4.7 km2 area of Accra, Ghana and a 151 km region along the highway represented the target areas for collecting photos of outdoor beverage ads. PRIMARY AND SECONDARY OUTCOME MEASURES: Number and types of beverage ads, sugar content of beverage products featured in ads and marketing themes used in ads. DESIGN: Two researchers photographed outdoor beverage ads in a 4.7 km2 area of Accra and used content analysis to assess marketing themes of ads, including the portrayal of children, local culture, music, sports and health. Researchers also recorded the number and type of ads along a 151 km stretch of the Accra-Cape Coast Highway. Researchers assessed the added sugar content to determine which beverages were sugar-sweetened beverages (SSBs). RESULTS: Seventy-seven photographed ads were analysed. Seventy-three per cent (72.7%) of ads featured SSBs, and Coca-Cola accounted for 59.7% of ads. Sixty-five per cent (64.9%) of all ads featured sodas, while 35.1% advertised energy drinks, bottled or canned juice drinks and coffee-based, milk-based and water-based beverages. Thirteen per cent (13%) of ads featured children and 5.2% were located near schools or playgrounds. Nine per cent (9.1%) of ads contained a reference to health and 7.8% contained a reference to fitness/strength/sport. Along the Accra-Cape Coast Highway, Coca-Cola accounted for 60% of branded ads. CONCLUSION: This study demonstrates the frequency of outdoor SSB ads within a 4.7 km2 area of Accra, Ghana. Coca-Cola was featured in the majority of ads, and the child-targeted nature of some ads indicates a need to expand the Children's Food and Beverage Advertising Initiative pledge to reduce child-targeted marketing on a global scale.

The metabolic syndrome is associated with higher ambulatory blood pressure. The authors studied the association of metabolic syndrome and masked hypertension (MHT) among African Americans with clinic-measured systolic/diastolic blood pressure (SBP/DBP) <140/90 mm Hg in the Jackson Heart Study. MHT was defined as daytime, nighttime, or 24-hour hypertension on ambulatory blood pressure monitoring. Among 359 participants not taking antihypertensive medication, the metabolic syndrome was associated with MHT (prevalence ratio, 1.38; 95% confidence interval, 1.10-1.74]). When metabolic syndrome components (clinic SBP/DBP 130-139/85-89 mm Hg, abdominal obesity, impaired glucose, low high-density lipoprotein cholesterol, high triglycerides) were analyzed separately, only clinic SBP/DBP 130-139/85-89 mm Hg was associated with MHT (prevalence ratio, 1.90; 95% confidence interval, 1.56-2.32]). The metabolic syndrome was not associated with MHT among participants not taking antihypertensive medication with SBP/DBP 130-139/85-89 and <130/85 mm Hg, separately, or among participants taking antihypertensive medication (n=393). Ambulatory blood pressure monitoring screening for MHT among African Americans should be considered based on clinic BP, not metabolic syndrome.

BACKGROUND: The optimal blood pressure (BP) target has been a matter of debate. The recent SPRINT trial showed significant benefits of a BP target of <120 mm Hg albeit with an increase in serious adverse effects related to low BP. METHODS: PUBMED, EMBASE, and CENTRAL were searched for randomized trials comparing treating to different BP targets. Trial arms were grouped into five systolic BP target categories: 1) <160 mm Hg; 2) <150 mm Hg; 3) <140 mm Hg; 4) <130 mm Hg and 5) <120 mm Hg. Efficacy outcomes of stroke, myocardial infarction, death, cardiovascular death, heart failure and safety outcomes of serious adverse effects were evaluated using a network meta-analysis. RESULTS: Seventeen trials that enrolled 55,163 patients with 204,103 patient-years of follow-up were included. There was a significant decrease in stroke (RR=0.54; 95% CI 0.29-1.00) and myocardial infarction (RR=0.68; 95% CI 0.47-1.00) with systolic BP <120 mm Hg (vs. <160 mm Hg). Sensitivity analysis using achieved systolic BP showed a 72%, 97% and 227% increase in stroke with systolic BP of <140 mm Hg, <150 mm Hg and <160 mm respectively, when compared with systolic BP <120 mm Hg. There was no difference in death, cardiovascular death or heart failure when comparing any of the BP targets. However, the point estimate favored lower BP targets (<120 mm Hg, <130 mm Hg) when compared with higher BP targets (<140 mm Hg or <150 mm Hg). BP targets of <120 mm Hg and <130 mm Hg ranked #1 and #2 respectively, as the most efficacious target. There was a significant increase in serious adverse effects with systolic BP <120 mm Hg vs. <150 mm Hg (RR=1.83; 95% CI 1.05-3.20) or vs. <140 mm Hg (RR=2.12; 95% CI 1.46-3.08). BP targets of <140 mm Hg and <150 mm Hg ranked #1 and #2 respectively, as the safest target for the outcome of serious adverse effects. Cluster plots for combined efficacy and safety showed that a systolic BP target of <130 mm Hg had optimal balance between efficacy and safety. CONCLUSIONS: In patients with hypertension, a systolic BP target of <130 mm Hg achieved optimal balance between efficacy and safety.

Blood pressure (BP) can differ substantially when measured in the clinic versus outside of the clinic setting. Few population-based studies with ambulatory blood pressure monitoring (ABPM) include African Americans. We calculated the prevalence of clinic hypertension and ABPM phenotypes among 1016 participants in the population-based Jackson Heart Study, an exclusively African-American cohort. Mean daytime systolic BP was higher than mean clinic systolic BP among participants not taking antihypertensive medication (127.1[standard deviation 12.8] vs. 124.5[15.7] mm Hg, respectively) and taking antihypertensive medication (131.2[13.6] vs. 130.0[15.6] mm Hg, respectively). Mean daytime diastolic BP was higher than clinic diastolic BP among participants not taking antihypertensive medication (78.2[standard deviation 8.9] vs. 74.6[8.4] mm Hg, respectively) and taking antihypertensive medication (77.6[9.4] vs. 74.3[8.5] mm Hg, respectively). The prevalence of daytime hypertension was higher than clinic hypertension for participants not taking antihypertensive medication (31.8% vs. 14.3%) and taking antihypertensive medication (43.0% vs. 23.1%). A high percentage of participants not taking and taking antihypertensive medication had nocturnal hypertension (49.4% and 61.7%, respectively), white-coat hypertension (30.2% and 29.3%, respectively), masked hypertension (25.4% and 34.6%, respectively), and a nondipping BP pattern (62.4% and 69.6%, respectively). In conclusion, these data suggest hypertension may be misdiagnosed among African Americans without using ABPM.

BACKGROUND: Poor medication adherence is a significant public health problem in patients with hypertension. The patient-physician relationship offers an ideal opportunity to address patient non-adherence as physicians' communication skills contribute to as much as 50%of the quality of care patients' receive. Despite this evidence, there is no empirical data on how the informational and relational aspects of patient-physician communication affect patient's actual medication-taking behaviors. The aim of this study was to evaluate the impact of patient-physician communication on medication adherence among a sample of primary care physicians and their Black and White hypertensive patients. METHODS: Cohort study of 92 hypertensive patients (mean age: 60 years) and 27 primary care physicians (mean age: 36 years) in two safety-net primary care practices in New York City. Patient-physician encounters were audiotaped at baseline; medication adherence data were gathered continuously over the 3- month study with an electronic monitoring device. Audiotape analyses of patient physician communication were coded using the Medical Interaction Process System. Six categories of communication were computed: 1) patient centeredness; 2) patient assertiveness; 3) psychosocial focus; 4) information exchange; 5) physician disclosure-promoting; and 6) physician verbal dominance. Frequencies of content codes were also calculated for the proportion of the discussion specific to: hypertension; antihypertensive medications; patient-physician social conversation; and discussions about patient's social circumstances (i.e., patient's living situation, relationship with spouse/partner). Adaptive statistical modeling methods based on likelihood cross validation were used to analyze the adherence data. RESULTS: The majority of patients were Black, 58% women, and most were seeing the same physician for at least 1 year. Approximately half of physicians were White (56%), 67% women, and have been in practice for 6 years. Fifty eight percent of patients exhibited poor adherence to prescribed antihypertensive medications. Two categories of patient-physician communication predicted poor medication adherence in the multivariate adaptive logistic regression model: fewer discussions about patients' social circumstances (OR: 6.03, 95CI:2.15- 17) and about their antihypertensive medications (OR: 5.64, 95CI:1.49-21.3). CONCLUSIONS: The odds of poor medication adherence are nearly six times greater when patient-physician interactions do not address patients' social circumstances or their medication regimen. These findings support the importance of adherence counseling and attending to the social determinants of health in routine care of low-income patients in ambulatory practices